$TDOC

DIVITA CHARLES III sold $109K of TDOC

DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 17,805 shares of Teladoc Health, Inc. (TDOC) at $6.10 ($0.11M total) on 2026-09-11.

Original reporting
SEC EDGAR · DIVITA CHARLES III
Published Sep 14, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The transaction is a routine diversification move with minimal market effect.

02

Market read

Low relevance; small insider sell unlikely to affect Teladoc's stock price.

03

What to watch

Potential upcoming dilution or compensation changes not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-14

Background

Form 4 filings disclose insider transactions; a CEO sale is publicly reported.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

CEO Divita Charles III sold 17,805 shares for $108,682 via a Form 4 filing.

Expected impact

No significant impact expected.

Evidence & confidence

Sale size is small relative to float and recent price; typical for diversification.

Market effects

None; Teladoc operates in digital health with no sector-wide impact from this sale.

None; the transaction is US‑based and limited to one insider.

None

Counterpoint

The sell could signal insider concern, but size is too small to be meaningful.

Key entities

  • Divita Charles III

    Chief Executive Officer of Teladoc Health

  • Teladoc Health, Inc.

    US‑listed telehealth provider (ticker TDOC)

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.